• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Oncology Town Hall 1/28

anonymous

Guest
Why did DA make a vague announcement in December now to say that they won’t have more information until March???? Does anyone reading this thread know any serious information??
 
















There are other open positions internally. Hiring a rare disease derm squad right now. Not a ton of positions, and there’s not much info on the comp package, ot does at least keep you with the ‘devil you know’ is some respects.